What are the risks of investing in CRISIL?
CRISIL Limited operates as a leading analytical company providing ratings, research, and risk advisory services, exposing investors to specific professional services risks. Key vulnerabilities include heavy dependence on macroeconomic activity, capital market fundraising volumes, and regulatory credit rating mandates that can fluctuate during economic downturns. Additional hazards comprise reputational risk where rating inaccuracies or perceived conflicts of interest can damage institutional credibility, intense competition from other domestic rating agencies, and wage inflation pressures impacting operational profit margins.
Related FAQs
CRISIL (Credit Rating Information Services of India Limited), being a premier global analytical company providing ratings, research, and risk advisory services primarily headquartered and operating in India, does not typically maintain a standard con...
Exide Industries Limited employs approximately eighteen thousand to nineteen thousand personnel operating within the industrial and automotive battery manufacturing sector.
CRISIL, an S&P Global company, operates primarily as an analytical firm providing ratings, research, risk advisory, and policy services to financial institutions, corporations, and government bodies.
CRISIL is not a United States-based company; its corporate headquarters are located in Mumbai, India, where it was originally founded.
Compensation structures at CRISIL Limited, a leading global analytical company providing ratings, research, and risk advisory services, vary based on analytical roles, financial research expertise, and corporate hierarchy bands.
CRISIL is not a government agency; rather, it is a publicly traded private enterprise listed on the Bombay Stock Exchange and the National Stock Exchange of India.
The corporate acronym CRISIL stands officially for Credit Rating Information Services of India Limited.
CRISIL is a subsidiary of S&P Global, which holds a controlling majority ownership stake in the Indian analytical enterprise.
Institutional equity research consensus price targets for CRISIL Limited average approximately Rs 4,950, with upper bull-case institutional projections reaching up to Rs 6,000 and conservative baseline forecasts near Rs 3,300.
Financial analysts frequently highlight CRISIL as a high-quality, debt-free or low-debt compounding stock characterized by strong recurring revenues and robust operating margins.
CRISIL Limited operates as a premier analytical company providing ratings, research, and risk advisory services, primarily in India and global markets.
CRISIL is widely recognized as a highly reputable, financially robust, and professionally managed global analytical enterprise.
CRISIL Limited, a premier Indian analytical company operating under the majority ownership of S&P Global, generates annual revenues translating to approximately $350 million to $380 million USD (surpassing ₹31 billion in regional exchange valuations)...
CRISIL evaluates mutual funds and financial instruments on a scale ranging from Rank 1 to Rank 5.
CRISIL (Credit Rating Information Services of India Limited) is a subsidiary of S&P Global, which owns a majority stake in the company.
Equity research analysts covering CRISIL Limited generally evaluate the stock favorably due to its dominant market share in domestic credit ratings, high return on capital employed, and strong cash generation.
CRISIL monetizes its extensive market expertise through three core operational pillars: ratings, research, and advisory services.
No, CRISPR Therapeutics (CRSP) does not pay a dividend to its shareholders, and it is considered highly unlikely to do so in the foreseeable future.
CRISIL Limited, India's premier credit rating, research, and risk advisory company, was originally incorporated in the late 1980s under the formal and descriptive name Credit Rating Information Services of India Limited.
CRISIL sells a broad portfolio of analytical services, independent credit ratings, financial research, risk management tools, and advisory solutions to corporations, financial institutions, and investors globally.
CRISIL operates as India's premier and pioneering credit rating agency, having established the market in the late 1980s.
CRISIL evaluates, ranks, and classifies mutual fund schemes across various asset classes—including equity, debt, and hybrid categories—to help investors compare fund performance objectively.
Yes, CRISIL is recognized for offering competitive compensation packages within the professional services and financial analysis industries in India.
CRISIL Limited shares trade actively on the National Stock Exchange of India, maintaining a live market price of approximately 4,370.80 Indian rupees per share.
The Center for Research in Security Prices (CRSP) indexes differ from the S&P 500 primarily in construction methodology, market breadth, and index philosophy. While the S&P 500 is a targeted benchmark tracking 500 leading U.S.